Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Preclinical profile of Pfizer's novel CRF1 receptor antagonist CP-376395

March 3, 2008

FDA approves Luvox CR Extended-Release capsules for SAD and OCD therapy

Feb. 29, 2008

Preliminary results reported from phase III NGX-4010 trial in HIV-DSP

Feb. 29, 2008

Positive pharmacokinetic study results of once-daily ondansetron

Feb. 29, 2008

YM-202074 confers neuroprotection in a stroke model

Feb. 29, 2008

Soluble CD40 ligand a marker of Alzheimer's disease severity, progression

Feb. 29, 2008

Cerebral ischemia greatly increases protein sumoylation

Feb. 29, 2008

FDA issues not approvable letter to Kyowa Hakko for istradefylline in Parkinson's

Feb. 28, 2008

Synthetic Blood awarded USD 1.9 million grant for phase IIb clinical trial of Oxycyte

Feb. 28, 2008

Addex achieves preclinical milestone in agreement with Merck & Co. for allosteric modulators

Feb. 28, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...